| Quarter | Holdings | Value, Excl. Options ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q3 2026 | 24 | 182,059 | CDNA, EPD, WGS, FIVN | 13F-HR | 11/6/2026 | 000101905626000153 |
| Q2 2026 | 23 | 157,257 | CDNA, AMRC, EPD, WGS | 13F-HR | 8/5/2026 | 000101905626000122 |
| Q1 2026 | 22 | 135,929 | EPD, AMRC, EQIX, NVGS | 13F-HR | 4/21/2026 | 000101905626000079 |
| Q4 2025 | 23 | 157,516 | WGS, AMRC, AL, EPD | 13F-HR | 2/12/2026 | 000101905626000036 |
| Q3 2025 | 24 | 161,954 | AMRC, WGS, FRSH, AL | 13F-HR | 11/3/2025 | 000101905625000229 |
| Q2 2025 | 24 | 148,814 | WGS, PSIX, AL, EPD | 13F-HR | 7/23/2025 | 000101905625000194 |
| Q1 2025 | 28 | 141,789 | EPD, WGS, AL, PSIX | 13F-HR | 5/12/2025 | 000101905625000175 |
| Q4 2024 | 26 | 156,191 | WGS, PSIX, EPD, AL | 13F-HR | 1/23/2025 | 000101905625000036 |
| Q3 2024 | 27 | 154,843 | PSIX, CDNA, WGS, EPD | 13F-HR | 11/12/2024 | 000101905624000314 |
| Q2 2024 | 27 | 131,346 | EPD, CDNA, AL, NVGS | 13F-HR | 8/14/2024 | 000101905624000244 |
| Q1 2024 | 27 | 115,264 | AL, EPD, NVGS, BL | 13F-HR | 5/13/2024 | 000101905624000167 |
| Q4 2023 | 26 | 114,480 | AL, NVGS, EPD, FIVN | 13F-HR | 2/14/2024 | 000101905624000094 |
| Q3 2023 | 28 | 119,537 | AL, NVGS, EPD, ETWO | 13F-HR | 11/14/2023 | 000101905623000395 |
| Q2 2023 | 29 | 149,441 | NVGS, AL, ETWO, NEWR | 13F-HR | 8/8/2023 | 000101905623000330 |
| Q1 2023 | 28 | 148,972 | NVGS, AL, NEWR, ETWO | 13F-HR | 4/10/2023 | 000101905623000203 |
| Q4 2022 | 29 | 148,156 | APEN, NVGS, AL, EPD | 13F-HR | 2/7/2023 | 000101905623000102 |
| Q3 2022 | 32 | 154,430 | NVGS, AMRC, PCRX, EPD | 13F-HR | 11/14/2022 | 000101905622000643 |
| Q2 2022 | 33 | 165,106 | PCRX, NVGS, AL, EPD | 13F-HR | 8/1/2022 | 000101905622000524 |
| Q1 2022 | 33 | 217,085 | PCRX, AMRC, AL, NVGS | 13F-HR | 5/9/2022 | 000101905622000376 |
| Q4 2021 | 34 | 251,749 | AOSL, PCRX, AMRC, NEWR | 13F-HR | 2/8/2022 | 000101905622000152 |
| Q3 2021 | 35 | 252,105 | CDNA, BL, AMRC, AOSL | 13F-HR | 11/12/2021 | 000101905621000589 |
| Q2 2021 | 32 | 263,102 | CDNA, AMRC, BL, FIVN | 13F-HR | 7/28/2021 | 000101905621000435 |
| Q1 2021 | 30 | 242,888 | CDNA, AMRC, AOSL, PCRX | RESTATEMENT | 7/28/2021 | 000101905621000433 |
| Q4 2020 | 29 | 222,461 | CDNA, AMRC, BL, FIVN | 13F-HR | 2/12/2021 | 000101905621000106 |
| Q3 2020 | 30 | 161,314 | AMRC, CDNA, PCRX, BL | 13F-HR | 11/12/2020 | 000101905620000562 |
| Q2 2020 | 26 | 138,944 | AMRC, CDNA, BL, PCRX | RESTATEMENT | 8/14/2020 | 000101905620000481 |
| Q1 2020 | 27 | 107,167 | AMRC, CDNA, BL, PCRX | 13F-HR | 5/11/2020 | 000101905620000312 |
| Q4 2019 | 32 | 178,379 | AL, AMRC, GFN, EVBG | 13F-HR | 2/14/2020 | 000101905620000154 |
| Q3 2019 | 32 | 161,282 | AL, AMRC, EQIX, GFN | 13F-HR | 11/8/2019 | 000101905619000635 |
| Q2 2019 | 33 | 175,183 | EVBG, CDNA, AL, AMRC | 13F-HR | 8/12/2019 | 000101905619000467 |
| Q1 2019 | 33 | 174,791 | CDNA, AMRC, EVBG, AL | 13F-HR | 5/13/2019 | 000101905619000285 |
| Q4 2018 | 31 | 142,288 | CDNA, RHT, GFN, AMRC | 13F-HR | 1/18/2019 | 000101905619000020 |
| Q3 2018 | 30 | 166,888 | CDNA, GFN, RHT, AMRC | 13F-HR | 11/13/2018 | 000101905618001064 |
| Q2 2018 | 29 | 157,967 | GFN, CDNA, RHT, NEWR | 13F-HR | 8/9/2018 | 000101905618000940 |
| Q1 2018 | 31 | 134,384 | GFN, RHT, AL, AMRC | 13F-HR | 5/9/2018 | 000101905618000595 |
| Q4 2017 | 30 | 136,423 | GFN, AL, FIVN, RHT | 13F-HR | 2/13/2018 | 000101905618000330 |
| Q3 2017 | 29 | 131,961 | GFN, FIVN, AL, RTEC | 13F-HR | 11/14/2017 | 000101905617000763 |
| Q2 2017 | 27 | 115,944 | GFN, AL, RHT, AMRC | 13F-HR | 7/20/2017 | 000101905617000610 |
| Q1 2017 | 27 | 109,848 | AL, GFN, LLFLQ, RHT | 13F-HR | 5/11/2017 | 000101905617000445 |
| Q4 2016 | 27 | 121,014 | AL, GFN, RTEC, RHT | 13F-HR | 2/14/2017 | 000101905617000185 |
| Q3 2016 | 28 | 126,648 | RTEC, AL, AOSL, RHT | 13F-HR | 11/14/2016 | 000101905616001645 |
| Q2 2016 | 26 | 118,270 | NVGS, RTEC, AL, RHT | RESTATEMENT | 8/24/2016 | 000101905616001508 |
| Q1 2016 | 23 | 113,370 | AL, EQIX, RTEC, GFN | 13F-HR | 5/3/2016 | 000101905616001286 |
| Q4 2015 | 23 | 135,075 | RHT, ATHN, EQIX, AL | 13F-HR | 2/16/2016 | 000101905616001069 |
| Q3 2015 | 23 | 122,917 | RHT, EQIX, ATHN, AL | 13F-HR | 10/16/2015 | 000101905615000815 |
| Q2 2015 | 23 | 146,059 | RHT, EQIX, AL, GFN | 13F-HR | 7/24/2015 | 000101905615000635 |
| Q1 2015 | 24 | 170,602 | GFN, RHT, EQIX, NVCN | 13F-HR | 5/12/2015 | 000101905615000479 |
| Q4 2014 | 23 | 166,116 | GFN, EQIX, RHT, ATHN | 13F-HR | 2/13/2015 | 000101905615000172 |
| Q3 2014 | 26 | 161,755 | GFN, NVCN, EQIX, ATHN | 13F-HR | 10/15/2014 | 000101905614001317 |
| Q2 2014 | 24 | 159,969 | GFN, NVCN, AL, EQIX | 13F-HR | 7/31/2014 | 000101905614000980 |
| Q1 2014 | 28 | 176,537 | NVCN, GFN, AL, ATHN | 13F-HR | 5/6/2014 | 000101905614000635 |
| Q4 2013 | 28 | 172,838 | NVDQ, GFN, NVCN, ATHN | 13F-HR | 2/6/2014 | 000101905614000139 |